| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/17/1990 | US4942169 Piperidine derivative and pharmaceutical composition |
| 07/17/1990 | US4942161 Adrenergic blocking agents for vision defects |
| 07/17/1990 | US4942160 Analgesics, antiinflammatory agents |
| 07/17/1990 | US4942037 Transdermal delivery systems |
| 07/17/1990 | CA2007732A1 Cyclohexaneacetamide derivatives |
| 07/17/1990 | CA2007472A1 Method for selectively blocking 5ht2 receptors |
| 07/17/1990 | CA1271767A1 DOPAMINE-.beta.-HYDROXYLASE INHIBITORS |
| 07/17/1990 | CA1271761A1 Bis(substituted methyl)-methyl-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/14/1990 | WO1990008315A1 Composition and method for treatment of senile dementia |
| 07/14/1990 | CA2046328A1 Composition and method for the treatment of senile dementia |
| 07/13/1990 | CA2007553A1 Cyclic amine compounds and their production |
| 07/12/1990 | WO1990007509A1 Diazabicycloalkane derivatives |
| 07/12/1990 | WO1990007341A1 Purified ciliary neurotrophic factor |
| 07/11/1990 | EP0377520A2 Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment |
| 07/11/1990 | EP0377518A2 Sustained release pharmaceutical composition |
| 07/11/1990 | EP0377488A1 Novel beta-adrenergic agonists |
| 07/11/1990 | EP0377147A2 Therapeutic transdermal system having physostigmine as the active ingredient, and process for its development |
| 07/11/1990 | EP0377112A1 Quinoxaline compounds and their preparation and use |
| 07/11/1990 | EP0376999A1 Method of reversing the side effects of epidural analgesics |
| 07/11/1990 | EP0376986A1 Chemical splinter removal |
| 07/11/1990 | EP0281608B1 Hydroxylindol derivatives |
| 07/11/1990 | CN1043700A Compounds for treatment of urinary incontinence |
| 07/10/1990 | WO1990007490A1 Halo substituted aminotetralins |
| 07/10/1990 | US4940795 Heterocyclic spiro compounds and methods for preparing the same |
| 07/10/1990 | US4940790 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6H-1,3,4-thiadiazines |
| 07/10/1990 | US4940789 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents |
| 07/10/1990 | US4940714 2-substituted carbonylimidazo[4,5-c]quinolines |
| 07/10/1990 | US4940704 Pyrido[3,4-b][1,4]benzoxazepines |
| 07/10/1990 | US4940703 Spirocyclic compounds incorporating five-membered rings with two heteroatoms for treating psychotic disorders, etc. |
| 07/10/1990 | US4940694 Therapeutic use of GM1 in severe cerebral ischemic strokes pathologies |
| 07/10/1990 | CA1271598A1 Pharmacologically active 5-oxo-1 imidazoldine acetamide compounds |
| 07/10/1990 | CA1271475A1 Pharmaceutical compositions having a psychotropic activity |
| 07/10/1990 | CA1271474A1 Substituted n-¬(4-piperidinyl)alkyl| bicyclic condensed oxazol- and thiazolamines |
| 07/05/1990 | DE3942729A1 Novel capsaicin derivs. |
| 07/05/1990 | CA2007117A1 Beta-adrenergic agonists |
| 07/04/1990 | EP0376899A2 Use of L-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies |
| 07/04/1990 | EP0376849A1 2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine derivatives, process and intermediates for their preparation, their pharmaceutical use and compositions containing them |
| 07/04/1990 | EP0376848A1 Thiazolyl or oxazolyl substituted 1,2,5,6-tetrahydropyridine derivatives, process and intermediates for their preparation, their use as medicaments and compositions containing them |
| 07/04/1990 | EP0376607A1 Piperazinyl derivatives |
| 07/04/1990 | EP0376358A1 Muscarinic receptor antagonists |
| 07/04/1990 | EP0376155A1 N-Pyridinyl-9H-carbazol-9-amines, a process for their preparation and their use as medicaments |
| 07/04/1990 | EP0376067A2 Transdermal therapeutic system having physostigmine as the active ingredient, and process for its development |
| 07/04/1990 | EP0375885A1 Aqueous elcatonin solution composition |
| 07/04/1990 | EP0375819A1 Novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones |
| 07/03/1990 | US4939274 Hydroxybutenolide derivatives, production and use thereof |
| 07/03/1990 | US4939259 2-oxo-pyrido[2,3-g]quinoline derivatives |
| 07/03/1990 | US4939175 Cognition activators; alzheimer*s disease |
| 07/03/1990 | US4939149 Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization |
| 07/03/1990 | US4939144 Tricyclic ketone derivatives as 5-HT antagonists |
| 07/03/1990 | US4939142 Substituted styrene derivatives |
| 07/03/1990 | US4939136 New anellated indole derivatives |
| 07/03/1990 | US4939133 N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade |
| 07/03/1990 | US4939129 Uses of 4-(3-phosphono-2-propenyl)-2-pierazinecarboxylic acid |
| 07/03/1990 | US4939126 1-pyrrolidineacetamide derivatives and use thereof |
| 07/03/1990 | CA1271193A1 Diazepinoindoles, their production and pharmaceutical compositions containing them |
| 06/28/1990 | WO1990006948A1 Mammalian gap-43 compositions and methods of use |
| 06/28/1990 | WO1990006937A1 Derivatives of tetrapeptides as cck agonists |
| 06/28/1990 | WO1990006934A1 Triple stranded nucleic acid and methods of use |
| 06/28/1990 | WO1990006927A1 5-ht selective agents |
| 06/28/1990 | WO1990006919A1 New thioproline derivative |
| 06/28/1990 | WO1990004387A3 Compositions for treating tobacco withdrawal symptoms |
| 06/27/1990 | EP0375560A1 Aryloxypropanolaminotetralines, process for their preparation and pharmaceutical compositions containing same |
| 06/27/1990 | EP0375536A1 Derivatives of 1,7'-(imidazo-(1,2-a)pyridine) 5'-(6'H) ones and process for their preparation |
| 06/27/1990 | EP0375520A1 Cosmetic or pharmaceutical composition containing microspheres of polymers or lipids charged with at least one active substance |
| 06/27/1990 | EP0375510A1 2-Imino-6-polyfluoroalcoxy-benzothiazole derivatives, process for their preparation and medicaments containing them |
| 06/27/1990 | EP0375504A1 Use of substituted benzamides as anxiolytics and antipsychotics |
| 06/27/1990 | EP0375450A2 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo(2.2.1) heptane, process for its preparation and pharmaceutical compositions containing it |
| 06/27/1990 | EP0375408A1 Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 06/27/1990 | EP0375210A1 Pyrazoloisoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/27/1990 | EP0374980A2 Percutaneous preparation of tulobuterol |
| 06/27/1990 | EP0374940A2 Polypeptides isolated from the venom of the spider hololena curta |
| 06/27/1990 | EP0374808A2 Xanthin derivatives having an adenosin-antagonist activity |
| 06/27/1990 | EP0374801A2 Novel N-sustituted azaheterocyclic carboxylic acids |
| 06/27/1990 | EP0374756A2 Nitrogen-containing cyclic compounds |
| 06/27/1990 | EP0374675A2 Reduction of piperidine-dion-derivatives and intermediates |
| 06/27/1990 | EP0374674A2 Etherification and dealkylation of piperidine derivatives and intermediates |
| 06/27/1990 | EP0374534A1 Quinoxaline compounds and their preparation and use |
| 06/26/1990 | US4937343 2-pyrimidinyl-1-piperazine derivatives |
| 06/26/1990 | US4937268 Chemical compounds |
| 06/26/1990 | US4937265 Oral administration of the composition admixed with a carrier |
| 06/26/1990 | US4937260 For treatment of psychosomatic diseases |
| 06/26/1990 | US4937251 Dichloroaniline compounds useful for method of therapy or prophylaxis of a disease associated with reversible airway obstruction |
| 06/26/1990 | US4937245 Antidepressants, anxiolytic agents |
| 06/26/1990 | US4937236 Anxiolytic N-substituted benzamides |
| 06/26/1990 | US4937235 3- or 4-substituted oxotremorine derivatives |
| 06/26/1990 | CA1270825A1 ¬7-(3-disubstituted amino)phenyl|-pyrazolo¬1,5- a|pyrimidines |
| 06/23/1990 | CA2006436A1 Compounds |
| 06/23/1990 | CA2006413A1 Nitrogen-containing ring compounds |
| 06/23/1990 | CA2006115A1 Capsaicin derivatives |
| 06/22/1990 | CA2006496A1 Mammalian gap-43 compositions and methods of use |
| 06/22/1990 | CA2005355A1 Reduction of piperidine-dion-derivatives and intermediates |
| 06/22/1990 | CA2005354A1 Etherification and dealkylation of piperidine derivatives and intermediates |
| 06/22/1990 | CA2004078A1 Quinoxaline compounds and their preparation and use |
| 06/22/1990 | CA2004077A1 Quinoxaline compounds and their preparation and use |
| 06/21/1990 | CA2006189A1 Derivatives of tetrapeptides as cck agonists |
| 06/20/1990 | EP0374042A2 Use of carbipramine in the preparation of a medicament for the treatment of anxiety and sleeping disorders |
| 06/20/1990 | EP0374041A1 Medicaments containing 2-benzothiazolamine derivatives, compounds and their preparation |
| 06/20/1990 | EP0374040A1 2-Imino-benzothiazoline derivatives, processes for their preparation and medicaments containing them |
| 06/20/1990 | EP0373998A1 Propenone oxime ethers, method for their preparation and pharmaceutical compositions containing them |
| 06/20/1990 | EP0373836A1 Improvements in or relating to serotonin and norepinephrine uptake inhibitors |